REFERENCES
1. Kato M, Natarajan R. Diabetic nephropathy--emerging epigenetic mechanisms. Nat Rev Nephrol. 2014;10:517-30.
2. AKh. Diabetic nephropathy - complications and treatment. Int J Nephrol Renovasc Dis. 2014;7:361-81.
3. Flyvbjerg A. The role of the complement system in diabetic nephropathy. Nat Rev Nephrol. 2017;13:311-8.
4. Sharma D, Bhattacharya P, Kalia K, Tiwari V. Diabetic nephropathy: new insights into established therapeutic paradigms and novel molecular targets. Diabetes Res Clin Pract. 2017;128:91-108.
5. Schwinghammer UA, Melkonyan MM, Hunanyan L, et al. α2-adrenergic receptor in liver fibrosis: implications for the adrenoblocker mesedin. Cells. 2020;9:456.
6. Wibowo DNSA, Soebadi DM, Soebadi MA. Yohimbine as a treatment for erectile dysfunction: a systematic review and meta-analysis. Turk J Urol. 2021;47:482-8.
7. Lin Y, Zhu X, Yao WZ, Yang YL, A LT, Chen L. Yohimbine protects against endotoxin-induced acute lung injury by blockade of alpha 2A adrenergic receptor in rats. Chin Med J. 2011;124:1069-74.
8. Jabir NR, Firoz CK, Zughaibi TA, et al. A literature perspective on the pharmacological applications of yohimbine. Ann Med. 2022;54:2861-75.
9. Miksa M, Das P, Zhou M, et al. Pivotal role of the alpha2A-adrenoceptor in producing inflammation and organ injury in a rat model of sepsis. PLoS One. 2009;4:e5504.
10. Huang R, Zhang Y, Han B, et al. Circular RNA HIPK2 regulates astrocyte activation via cooperation of autophagy and ER stress by targeting MIR124-2HG. Autophagy. 2017;13:1722-41.
11. Qu S, Yang X, Li X, et al. Circular RNA: a new star of noncoding RNAs. Cancer Lett. 2015;365:141-8.
12. Han B, Chao J, Yao H. Circular RNA and its mechanisms in disease: from the bench to the clinic. Pharmacol Ther. 2018;187:31-44.
13. Peng F, Gong W, Li S, et al. circRNA_010383 acts as a sponge for miR-135a, and its downregulated expression contributes to renal fibrosis in diabetic nephropathy. Diabetes. 2021;70:603-15.
14. Hu W, Han Q, Zhao L, Wang L. Circular RNA circRNA_15698 aggravates the extracellular matrix of diabetic nephropathy mesangial cells via miR-185/TGF-β1. J Cell Physiol. 2019;234:1469-76.
15. Zhang SJ, Chen X, Li CP, et al. Identification and characterization of circular RNAs as a new class of putative biomarkers in diabetes retinopathy. Invest Ophthalmol Vis Sci. 2017;58:6500-9.
16. Ernst E, Pittler MH. Yohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized clinical trials. J Urol. 1998;159:433-6.
17. Bahreini E, Rezaei-Chianeh Y, Nabi-Afjadi M. Molecular mechanisms involved in intrarenal renin-angiotensin and alternative pathways in diabetic nephropathy - a review. Rev Diabet Stud. 2021;17:1-10.
18. Dawood AF, Maarouf A, Alzamil NM, et al. Metformin is associated with the inhibition of renal artery AT1R/ET-1/iNOS axis in a rat model of diabetic nephropathy with suppression of inflammation and oxidative stress and kidney injury. Biomedicines. 2022;10:1644.
19. Pizzino G, Irrera N, Cucinotta M, et al. Oxidative stress: harms and benefits for human health. Oxid Med Cell Longev. 2017;2017:8416763.
20. Rotariu D, Babes EE, Tit DM, et al. Oxidative stress - complex pathological issues concerning the hallmark of cardiovascular and metabolic disorders. Biomed Pharmacother. 2022;152:113238.
21. Mehta MM, Weinberg SE, Chandel NS. Mitochondrial control of immunity: beyond ATP. Nat Rev Immunol. 2017;17:608-20.
22. Wang Y, Cui J, Liu M, Shao Y, Dong X. Schisandrin C attenuates renal damage in diabetic nephropathy by regulating macrophage polarization. Am J Transl Res. 2021;13:210-22.
23. Sharma N, Sistla R, Andugulapati SB. Yohimbine ameliorates liver inflammation and fibrosis by regulating oxidative stress and Wnt/β-catenin pathway. Phytomedicine. 2024;123:155182.
24. Iciek M, Górny M, Kotańska M, Bilska-Wilkosz A, Kaczor-Kamińska M, Zagajewski J. Yohimbine alleviates oxidative stress and suppresses aerobic cysteine metabolism elevated in the rat liver of high-fat diet-fed rats. Molecules. 2023;28:2025.
25. Ansari MM, Khan HA. Yohimbine hydrochloride ameliorates collagen type-II-induced arthritis targeting oxidative stress and inflammatory cytokines in Wistar rats. Environ Toxicol. 2017;32:619-29.
26. Veeram A, Shaikh TB, Kaur R, Chowdary EA, Andugulapati SB, Sistla R. Yohimbine treatment alleviates cardiac inflammation/injury and improves cardiac hemodynamics by modulating pro-inflammatory and oxidative stress indicators. Inflammation. 2024;47:1423-43.
27. Liang Y, Shen L, Ni W, et al. CircGNB1 drives osteoarthritis pathogenesis by inducing oxidative stress in chondrocytes. Clin Transl Med. 2023;13:e1358.
28. Hu J, Zhang G, Wang Y, et al. CircGNB1 facilitates the malignant phenotype of GSCs by regulating miR-515-5p/miR-582-3p-XPR1 axis. Cancer Cell Int. 2023;23:132.
